JPRN-UMIN000007927
Completed
未知
A feasibility trial of cord blood cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen - A feasibility trial of cord blood cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen (ATL-NST-5)
Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan0 sites15 target enrollmentMay 14, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) A patient is uneligible if he (she) has (a) to (d). (a) Resting ejection fraction bellow 50% by UCG. (b) SaO2 bellow 90% in room air. (c) Serum Cr level above 2\.0 mg/dL. (d) CCr bellow 20 mL/min/m2\. (e) T.Bil level above 2\.0 mg/dL or GPT over 4 times of upper limit. (2\) Uncontrollable active infection. (3\) Active CNS lesion at registration. (4\) Woman who is pregnant, possibly pregnant or breast feeding (5\) On or taking major tranquilizer, antidepressant, antimanic. (6\) History of adverse reaction for the agents included in the protocol in conditioning (fludarabine, melphalan), in GVHD prophylaxis (tacrorimus, MMF, steroids) and G\-CSF. (7\) Recipient of previous allogeneic hematopoietic stem cell transplantation. (8\) Positive for HIV antibody. (9\) Positive for HBs antigen. (10\) Have an active cancer.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndromeJPRN-UMIN000000868Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare28
Completed
Not Applicable
A phase II study of Cord blood transplantation for elderly patients with myeloid malignancies using fludarabine and intravenous busulfan in addition to cytarabine and G-CSF.AML,MDSJPRN-UMIN000010698JSCT30
Completed
Phase 2
Safety and efficacy of cord blood transplantation for hematologic malignancies (OCU 9-2)Acute myeloid leukemia AML with multilineage dysplasia Myelodysplastic syndrome Acute lymphoblastic leukemia Chronic myeloid leukemia Adult T cell leukemia/lymphoma Malignant lymphomaJPRN-UMIN000002214Hematology, Osaka City University, Graduate School of Medicine20
Completed
Not Applicable
Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem CellsAllogeneic Stem Cell TransplantationNCT01092026Universitair Ziekenhuis Brussel11
Completed
Not Applicable
Clinical trial related with transplantation therapy with human autologous cell mixed sheets for refractory cutaneous ulcerrefractory cutaneous ulcerJPRN-UMIN000031645Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine6